Table 1.
Patient and disease characteristics according to treatment assignment used by Adjuvant! Online to provide estimates of outcome
| Characteristics | OFS-Tam (n = 85) | OFS-AC-Tam (n = 89) | Total (n = 174) |
|---|---|---|---|
| Age, years | |||
| Median | 46 | 45 | 45 |
| Range | 26 – 54 | 27 – 56 | 26 – 56 |
| Estrogen receptor status, % | |||
| Positive | 99 | 94 | 97 |
| Negative | 1 | 6 | 3 |
| Number of positive nodes, % | |||
| 0 | 0 | 0 | 0 |
| 1 – 3 | 95 | 98 | 97 |
| 4 – 9 | 4 | 2 | 3 |
| Greater than 9 | 1 | 0 | 1 |
| Tumor size, % | |||
| 0 cm | 1 | 0 | 1 |
| 0.1 – 1.0 cm | 7 | 12 | 10 |
| 1.1 – 2.0 cm | 45 | 48 | 47 |
| 2.1 – 3.0 cm | 38 | 28 | 33 |
| 3.1 – 5.0 cm | 7 | 9 | 8 |
| > 5.0 cm | 0 | 0 | 0 |
| Undefined | 2 | 2 | 2 |
| Tumor grade, % | |||
| 1 | 24 | 20 | 22 |
| 2 | 52 | 54 | 53 |
| 3 | 22 | 25 | 24 |
| Undefined | 2 | 1 | 2 |
| Comorbidities, % | |||
| Present | 12 | 11 | 11 |
Abbreviations: OFS, ovarian function suppression; Tam, tamoxifen; AC, doxorubicin (or epirubicin) and cyclophosphamide